EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance

Turky Omar Asar iD, Omar D Al-Hejaili, Hossam S El-Sawy iD, Fathy I Abd-Allah, Abdelsattar M Omar iD, Tarek A Ahmed, Khalid M El-Say iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s504291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Turky Omar Asar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Pyrimidines, Phosphodiesterase 5 Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesPhosphodiesterase 5 InhibitorsBiological AvailabilityTabletsHumansAdministration, OralAdministration, SublingualMaleSolubilityAdult2-Hydroxypropyl-beta-cyclodextrinYoung AdultPolyethylene Glycols

Stichwörter der Autor:innen

avanafilerectile dysfunctioninclusion complexpharmacokinetic studysublingual tablets

Substanzen

TabletsavanafilPyrimidines2-Hydroxypropyl-beta-cyclodextrinPhosphodiesterase 5 InhibitorsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah, Saudi Arabia.
  • Department of Pharmaceutics, Faculty of Pharm Saudi Arabia Acy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
  • Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Egyptian Russian University, Cairo, 11829, Egypt.
  • College of Pharmacy, Kut University, Wasit, 52001, Iraq.
  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, 11651, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

ORCID-Profile: Turky Omar Asar, Hossam S El-Sawy, Abdelsattar M Omar, Khalid M El-Say

Zitieren

APA

Asar, T. O., Al-Hejaili, O. D., El-Sawy, H. S., Abd-Allah, F. I., Omar, A. M., Ahmed, T. A., & El-Say, K. M. (2025). From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s504291

Vancouver

Asar TO, Al-Hejaili OD, El-Sawy HS, Abd-Allah FI, Omar AM, Ahmed TA, et al. From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s504291

BibTeX
@article{Asar2025,
  author = {Asar, Turky Omar and Al-Hejaili, Omar D and El-Sawy, Hossam S and Abd-Allah, Fathy I and Omar, Abdelsattar M and Ahmed, Tarek A and El-Say, Khalid M},
  title = {From Oral to Sublingual: A Redefined Avanafil Tablet with a Breakthrough in Bioavailability and First-Pass Metabolism Avoidance},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s504291}
}
Kostenlos starten →